Header

Header

Acorda

Biology

November 20, 2022
147

New patent expiration for Acorda drug INBRIJA – DrugPatentWatch
Latest News

October 16, 2022
146

Acorda Therapeutics Announces $16.5M Award and Royalty/Supply Relief in AMPYRA® Arbitration Case
Latest News

December 25, 2018
141

ADDING MULTIMEDIA Acorda Therapeutics Announces FDA Approval of INBRIJA™ (levodopa inhalation powder)
Latest News

December 22, 2018
136

Acorda Therapeutics Announces FDA Approval of INBRIJA™ (levodopa inhalation powder)